Canoui-Poitrine F, Revuz JE, Wolkenstein P et al. Clinical characteristics of a series of 302

French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009;61:51–7.

Collier F, Smith R, Morton C. Diagnosis and management of hidradenitis suppurativa. BMJ. 2013;346:f2121.

Crowley JJ, Mekkes JR, Zouboulis CC et al. Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. Br J Dermatol 2014;171:1561–65. Fitzsimmons JS, Guilbert PR. A family study of hidradenitis suppurativa. J Med Genet 1985;22:367-73.

Hidradenitis Suppurativa Trust. Common Questions and Answers. Beschikbaar op Geraadpleegd mei 2016.

Irish Skin Foundation. Suppurativa hydradenitis. HS FAQS (01 september 2015). Beschikbaar op Geraadpleegd mei 2016.

Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366:158-64.

Kromann CB, Deckers IE, Esmann S et al. Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol 2014;171:819–24.

National Organisation for Rare Disease (NORD). Hidradenitis suppurativa. Beschikbaar op Geraadpleegd mei 2016. Pink AE, Simpson MA, Desai N et al. Mutations in the gamma-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa). J Invest Dermatol 2012;132:2459–61.

Sartorius K, Emtestam L, Jemec GB et al. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009;161: 831-9. Schrader AM, Deckers IE, van der Zee HH et al. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 2014;71:460–7.

Sørensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg. 2012;147(4):373-83.

Vazquez BG, Alikhan A, Weaver AL et al. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol 2013;133:97–103.

Zouboulis CC, del Marmol V, Mrowietz U et al. Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 2015b;231:184–90.

Zouboulis CC, Desai N, Emtestam L et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015a;29:619–44.